Jyothi Padiadpu
Cited by
Cited by
Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson’s disease: a dynamic model
S Vali, RB Mythri, B Jagatha, J Padiadpu, KS Ramanujan, JK Andersen, ...
Neuroscience 149 (4), 917-930, 2007
Complete Genome Sequences of a Mycobacterium smegmatis Laboratory Strain (MC2 155) and Isoniazid-Resistant (4XR1/R2) Mutant Strains
A Mohan, J Padiadpu, P Baloni, N Chandra
Genome announcements 3 (1), e01520-14, 2015
Network approaches to drug discovery
N Chandra, J Padiadpu
Expert opinion on drug discovery 8 (1), 7-20, 2013
Identifying and tackling emergent vulnerability in drug-resistant mycobacteria
J Padiadpu, P Baloni, K Anand, MH Munshi, C Thakur, A Mohan, A Singh, ...
ACS infectious diseases 2 (9), 592-607, 2016
Microbiota and adipocyte mitochondrial damage in type 2 diabetes are linked by Mmp12+ macrophages
Z Li, M Gurung, RR Rodrigues, J Padiadpu, NK Newman, NP Manes, ...
Journal of Experimental Medicine 219 (7), e20220017, 2022
Identifying feasible metabolic routes in Mycobacterium smegmatis and possible alterations under diverse nutrient conditions
P Baloni, J Padiadpu, A Singh, KR Gupta, N Chandra
BMC microbiology 14, 1-15, 2014
Protein–protein interaction networks suggest different targets have different propensities for triggering drug resistance
J Padiadpu, R Vashisht, N Chandra
Systems and synthetic biology 4, 311-322, 2010
Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome
NK Newman, Y Zhang, J Padiadpu, CL Miranda, AA Magana, CP Wong, ...
Microbiome 11 (1), 208, 2023
Probing the druggability limits for enzymes of the NAD biosynthetic network in glioma
J Padiadpu, M Mishra, E Sharma, U Mala, K Somasundaram, N Chandra
Journal of Chemical Information and Modeling 56 (5), 843-853, 2016
Gene expression profiles of wild-type and isoniazid-resistant strains of Mycobacterium smegmatis
J Padiadpu, P Baloni, N Chandra
Data in Brief 4, 186-189, 2015
Rationalization and prediction of drug resistant mutations in targets for clinical anti-tubercular drugs
J Padiadpu, S Mukherjee, N Chandra
Journal of Biomolecular Structure and Dynamics 31 (1), 44-58, 2013
Multi-omic network analysis identified betacellulin as a novel target of omega-3 fatty acid attenuation of western diet-induced nonalcoholic steatohepatitis
J Padiadpu, M Garcia-Jaramillo, N Newman, J Pederson, R Rodrigues, ...
EMBO Mol Med 15 (e18367), 2023
Early transcriptome changes associated with western diet induced NASH in Ldlr-/-mice points to activation of hepatic macrophages and an acute phase response.
J Padiadpu, MH Spooner, Z Li, N Newman, DK Apperson, CV Löhr, ...
Front. Nutr., 07 August 2023 Sec. Nutrigenomics 10, 2023
Metabolic Network Analysis: Implication And Application
RSDS Syed Asad Rahman, Pardha Saradhi Jonnalagadda, Jyothi Padiadpu, Kai ...
BMC Bioinformatics 6 (S12), 2005
Intestinal IL-22RA1 signaling regulates intrinsic and systemic lipid and glucose metabolism to alleviate obesity-associated disorders
SJ Gaudino, A Singh, H Huang, J Padiadpu, M Jean-Pierre, C Kempen, ...
Nature Communications 15 (1), 1597, 2024
Suppression of Betacellulin expression is a key mechanism for omega-3 fatty acid mediated attenuation of nonalcoholic steatohepatitis
J Padiadpu, M Garcia-Jaramillo, N Newman, J Pederson, R Rodrigues, ...
bioRxiv, 2022
An Integrated Systems Biology Approach to Study Drug Resistance in Mycobacteria
J Padiadpu
Transkingdom Network Analysis (TkNA): a systems framework for inferring causal factors underlying host–microbiota and other multi-omic interactions
NK Newman, MS Macovsky, RR Rodrigues, AM Bruce, JW Pederson, ...
Nature Protocols, 1-29, 2024
The system can't perform the operation now. Try again later.
Articles 1–18